The management of hepatocellular carcinoma in Asia: A guideline combining quantitative and qualitative evaluation

BioScience Trends

Volumn 4, Issue 6, 2010, Pages 283-287

  Song, Peipei ^a   Tang, Wei ^a   Tamura, Sumihito ^a   Hasegawa, Kiyoshi ^a   Sugawara, Yasuhiko ^a   Dong, Jiahong ^b   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Evidence based; Guideline; Hepatocellular carcinoma; Qualitative indicator

Indexed keywords

ARTICLE; ASIA; CHINA; EVIDENCE BASED MEDICINE; FEMALE; HEALTH; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; ONCOLOGY; PRACTICE GUIDELINE; SOUTH KOREA; TREATMENT OUTCOME;

ASIA; CARCINOMA, HEPATOCELLULAR; CHINA; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; REPUBLIC OF KOREA; TREATMENT OUTCOME; WORLD HEALTH;

EID: 79955670033     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132:2557-2576.
2. Benson AB 3rd, Abrams TA, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: Hepatobiliary cancers. J Natl Compr Canc Netw. 2009; 7:350-391.
3. Nelson M, Mendoza N, McGough N. A survey of provision of dietetic services for coeliac disease in the UK. J Hum Nutr Diet. 2007; 20:403-411.
4. Artz AS, Somerfield MR, Feld JJ, Giusti AF, Kramer BS, Sabichi AL, Zon RT, Wong SL. American Society of Clinical Oncology provisional clinical opinion: Chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol. 2010; 28:3199-3202.
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001; 35:421-430.
6. Park JW. Korean Liver Cancer Study Group and National Cancer Center. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol. 2004; 10:88-98. (in Korean)
7. Group formed to establish "guidelines for evidencebased clinical practice for the treatment of liver cancer". Clinical practice guidelines for hepatocellular carcinoma. Kanehara, Tokyo, Japan, 2005.
8. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005; 42:1208-1236.
9. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010; 4:439-474.
10. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements. J Gastroenterol Hepatol. 2010; 25:657-663.
11. Yuen MF, Hou JL, Chutaputti A. Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009; 24:346-353.
12. Parkin M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74-108.
13. Korean Liver Cancer Study Group and National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol. 2009; 15:391-423. (in Korean)
14. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: The first evidence based guidelines from Japan. World J Gastroenterol. 2006; 12:828-829.
15. Kokudo N, Sasaki Y, Nakayama T, Makuuchi M. Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians. Gut. 2007; 56:1020-1021.
16. Izumi N. Diagnostic and treatment algorithm of the Japanese society of hepatology: A consensus-based practice guideline. Oncology. 2010; 78 (Suppl 1):78-86.
17. Kudo M, Han KH, Kokudo N, Cheng AL, Choi BI, Furuse J, Izumi N, Park JW, Poon RT, Sakamoto M. Liver Cancer Working Group report. Jpn J Clin Oncol. 2010; 40 (Suppl 1):i19-i27.
18. Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines. J Gastroenterol. 2009; 44:119-121.
19. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res. 2010; 40 (Suppl 1):2-144.
20. Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, Yamaoka Y. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008; 38:37-51.
21. Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, Yamashita T, Kokudo N, Tanaka M, Takayama T, Kudo M. Management of hepatocellular carcinoma: Report of consensus meeting in the 45th annual meeting of the Japan Society of Hepatology (2009). Hepatol Res. 2010; 40:667-685.
22. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, Shih YT. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987; 257:2597-2603.
23. Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, Hsu HM, Chen HL, Hsu HY, Chen DS. Taiwan Childhood Hepatoma Study Group. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA. 2000; 284:3040-3042.
24. The Medical Administration Department of the Ministry of Health of the People's Republic of China. Treatment Standards for Common Malignant Tumors in China (Vol. 2, Hepatocellular Carcinoma). Beijing Medical University and Peking Union Medical College Press, Beijing, China, 1989.
25. The Drug Administration Department of the Ministry of Health of the People's Republic of China. Guiding Principles for Clinical Research on Treatment of Hepatocellular Carcinoma Involving New Drugs/Traditional Chinese Medicines. China Journal of Traditional Chinese Medicine and Pharmacy. 1990; 5:76-78. (in Chinese)
26. Chinese Anti-Cancer Association. New Treatment Standards for Common Malignant Tumors in China (Hepatocellular Carcinoma Section). Beijing Medical University and Peking Union Medical College Press, Beijing, China, 1999.
27. Chinese Liver Cancer Study Group. Choices for hepatocellular carcinoma treatment therapies. Chinese Journal of Bases and Clinics in General Surgery. 2001; 2:85-86. (in Chinese)
28. Chinese Anti-Cancer Association Society of Liver Cancer, Chinese Society of Clinical Oncology, Chinese Society of Hepatology Liver Cancer Study Group. The expert consensus on the treatment standards for hepatocellular carcinoma. Digestive Disease and Endoscopy. 2009; 3:40-51. (in Chinese).
29. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH. Asian Oncology Summit. Management of hepatocellular carcinoma in Asia: Consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009; 10:1111-1118.